Home » Bacteriophage Market

Bacteriophage Market By Product (Phage Probiotics, Phage Therapeutics) By Route of Administration (Oral, Topical, Others) By Application (Gastroenterology, Respiratory Infection Treatment, Skin Infection Treatment, Wound Prophylaxis, Urogenital Infection Treatment, Others) By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) – Growth, Future Prospects & Competitive Analysis, 2016 – 2028

Price: $4999

Published: | Report ID: 2114 | Report Format : PDF

How will an Increase in Anti-Biotic Resistance Infection Supports Market Growth?

According to CDC, approximately 2.8 million antibiotic-resistant infections occur in the US and approximately 35,000 patients die as a result of antibiotic-resistant infections. Antibiotics are becoming increasingly ineffective as antibiotic resistance spreads over the world, resulting in more difficult-to-cure illnesses and fatalities. New antibacterial medicines, for example, are required to combat carbapenem-resistant gram-negative infectious illnesses, which the World Health Organization has designated as a concern pathogen. Multidrug-resistant bacteria can be fought and killed by biological entities with the help of Bacteriophages. When all other antibiotics fail to treat an infection, phages can eradicate the bacteria that is causing the infection, allowing medical professionals to preserve life.  The increased prevalence of antibiotic-resistant infections, as well as the development of multidrug-resistant microorganisms, are driving the growth of the Bacteriophages Therapy Market. Thus with the rising prevalence of antibiotic resistance infection, the demand for Bacteriophages will increase

What is the Market Size of the Bacteriophage Market in terms of value?

Global Bacteriophage Market is projected to increase at a significant CAGR of 3.5 % in the coming years. In 2021, the global Bacteriophage Market was valued at USD 1,172.5 Million and is projected to reach at value of USD 1,441.3 million by 2028. The demand for Bacteriophage is projected to increase substantially in the coming years and is presumed to generate revenue opportunity for the key industry players that worth USD 268.8 million during the forecast period between 2022 and 2028.

Bacteriophage Market

How will the use of Phage Probiotics Benefit the Market?

Bacteriophage probiotics are gaining popularity all over the world. The development of phage probiotics offers a better alternative to traditional probiotic supplements. Bacteriophage probiotics aid in the improvement of intestinal health. The use of bacteriophages in gastroenterology has significantly grown because of these benefits. The human gastrointestinal (Gl) tract is inhabited by a diverse array of bacteria. Several variables, including nutrition and antibiotic therapy, can affect the beneficial bacterial flora of the gut, resulting in a variety of chronic and degenerative disorders in children and the elderly. Phage probiotics are so being developed to boost gastrointestinal health.

Interesting Facts about Bacteriophage Industry

  • The Bacteriophage market is predicted to increase at a substantial rate due to rising antibiotic resistance infection manufacturing, rising research efforts for therapy development, and rising adoption of growth methods like acquisitions and collaborations by industry participants.
  • The bacteriophage therapy market will face challenges due to a lack of healthcare infrastructure in developing economies and a stringent regulatory environment.
  • In terms of market share and revenue, North America dominates the bacteriophages therapy market and will maintain its dominance throughout the projection period.
  • In terms of product, the phage probiotics sector held around 95.5 percent of the market in 2021. This product’s popularity stems from its ability to improve gut flora diversity and promote the growth of beneficial bacteria.
  • The oral mode of administration benefits the most, accounting for a major share of revenue over the forecast period. This is the recommended method of administration because it is self-administrable, non-invasive, and cost-effective.

Who are the Top 10 players/companies in the Bacteriophage Market in terms of value and volume?

The key players in the global Bacteriophage Market in terms of value and volume are Eliava Biopreparations Ltd., Pherecydes Pharma, Armata Pharmaceuticals, Inc., Phagel ux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., Techno Phage, Eligo Bioscience SA, Phagomed Biopharma GmbH., Phage Pro, Inc., Intralytix, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intode world, Inc., BiomX Ltd., Fixed-phage Ltd., Micreos BV, Contra Fect Corporation, Phi Therapeutics, and OPTIPHARM Co., Ltd. The key players are working on different strategies such as product launch, acquisitions, partnerships, collaborations, and others to enhance their market presence.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Who are the Top 10 Countries in the Bacteriophage Market?

In the global Bacteriophage Market, the major countries are US, Canada, China, India, Japan, Australia, Germany, UK, France, and Israel. The United States leads the bacteriophages market in North America during the projected period. The increased prevalence of antibiotic resistance and rising demand for antibiotic alternatives in the country are driving market growth. The bacteriophages industry is expanding due to increased government funding and investment in novel approaches to treat antibiotic-resistant bacterial illnesses. Another important element assisting market expansion in the United States is the rising demand for phage probiotics as a probiotic supplement to promote gut health. Furthermore, the country’s top manufacturers are eager to increase the market footprint of their key products and solutions. Many renowned manufacturers now provide improved solutions based on bacteriophage supplements for this purpose. Thus driving the growth of the market in the nation in the coming years.

Which is the Key Application Area in the Bacteriophage Market?

The key applications of the Bacteriophage Market include Gastroenterology, Respiratory Infection Treatment, Skin Infection Treatment, Wound Prophylaxis, Urogenital Infection Treatment, and Others. Gastroenterology is creating a big opportunity for Bacteriophage Probiotic Manufacturers. Gut health is becoming a major public health concern, and phage supplements fill an unmet demand by protecting the gut from harmful bacteria. As a result, the gastroenterology industry is likely to drive bacteriophage demand in the approaching years. The majority of bacteriophage supplements are intended to promote gut health. In many places, the USFDA has yet to approve bacteriophages as a therapy option for certain antibiotic-resistant diseases. As a result, only phage probiotics are currently used by various professionals to improve and treat gut health issues.

What are the Major Driving Factors for Bacteriophage Market?

The increase in the prevalence rate of foodborne infections around the world will be a primary driver of the market’s growth rate. Another key element affecting the growth rate of the bacteriophages therapy market is rising healthcare expenditure, which aids in infrastructure improvement. Furthermore, numerous government organizations intend to improve healthcare infrastructure by boosting financing, which would have an impact on market dynamics. Antimicrobial-resistant infections are becoming more common, resulting in greater healthcare spending and an increase in the number of deaths. The increasing occurrence of antibiotic-resistant illnesses is likely to boost market growth. Furthermore, an increasing number of government measures to raise awareness and increase in the aging population would result in the bacteriophage therapy market expanding. Along with this, people’s changing lifestyles and rising levels of disposable money would boost the market’s growth rate.

What are the Major Restraints for Bacteriophage Market?

The high cost of bacteriophages therapy would impede the growth rate of the bacteriophages therapy market during the forecast period. The bacteriophage therapy market will face challenges due to a lack of healthcare infrastructure in developing economies and a stringent regulatory environment. Furthermore, a lack of awareness among people and the availability of alternatives may hinder and impede the market’s growth rate during the projection period.

Which Region Dominated the World Bacteriophage Market?

In terms of market share and revenue, North America dominates the bacteriophages therapy market and will maintain its dominance throughout the projection period. This is because bacteriophage provides quick recovery and therapeutic impact, and rising healthcare expenditure would further boost the market’s development rate in this region. The fundamental characteristics of the North American market are a strong desire to alleviate the burden of antibiotic-resistant illnesses, a well-established research infrastructure, and the presence of a prospective pipeline for phage therapy. Furthermore, the presence of major key players and the increased acceptance of newer technologies would accelerate the market’s growth rate in this area.

Asia-Pacific is predicted to be the fastest-growing region during the forecast period due to increased investment in creative R&D for novel drug products in this area Furthermore, the expansion of healthcare infrastructure and rising government efforts would accelerate the market’s growth rate in this region. Rapidly growing biotechnology infrastructure, altering agricultural methods, and similarly supportive government activities all contribute to the Asia Pacific market’s rapid growth.

Segmentation of Global Bacteriophage Market-

Bacteriophage Market- By Product

  • Phage Probiotics
  • Phage Therapeutics

Bacteriophage Market- By Route of Administration

  • Oral
  • Topical
  • Others

Bacteriophage Market- By Application

  • Gastroenterology
  • Respiratory Infection Treatment
  • Skin Infection Treatment
  • Wound Prophylaxis
  • Urogenital Infection Treatment
  • Others

Bacteriophage Market- By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Recent News and Development

UK Researchers Receive £800,000 Grant to Advance Bacteriophage Therapy (Source)

The University of Leicester has received an £800,000 grant from the Biotechnology and Biological Sciences Research Council (BBSRC) to develop bacteriophages to combat disease. Bacteriophages are viruses that infect and kill bacteria. They are naturally occurring and have the potential to be used as a new type of antibiotic.

The grant will be used to develop and commercialize a bacteriophage-based product to prevent Salmonella infections in broiler chickens. The researchers will also investigate ways to scale up the production of bacteriophages so that they can be used to treat a wider range of bacterial infections in animals and humans.

The development of bacteriophages to combat disease is a promising new approach to addressing the growing threat of antimicrobial resistance. The BBSRC grant is a significant investment in this area and is likely to accelerate the development of new and effective bacteriophage-based therapies.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Points

  • The University of Leicester has received an £800,000 grant to develop bacteriophages to combat disease.
    Bacteriophages are viruses that infect and kill bacteria.
  • The grant will be used to develop and commercialize a bacteriophage-based product to prevent Salmonella infections in broiler chickens.
  • The researchers will also investigate ways to scale up the production of bacteriophages so that they can be used to treat a wider range of bacterial infections in animals and humans.
  • The development of bacteriophages to combat disease is a promising new approach to addressing the growing threat of antimicrobial resistance.

Analyst View

  • Increased investment in bacteriophage research and development: The grant is a sign that there is growing interest in bacteriophages as a potential solution to the problem of antibiotic resistance. This is likely to lead to increased investment in bacteriophage research and development, which could lead to new and more effective bacteriophage-based therapies.
  • New market opportunities for bacteriophage-based products: The development of new bacteriophage-based therapies could create new market opportunities for companies that develop and manufacture these products. This could be particularly beneficial for companies that are developing bacteriophage-based therapies for veterinary use, as the grant is specifically aimed at advancing the production of phages to combat disease in the veterinary field.
  • Increased awareness of bacteriophages as a potential treatment for bacterial infections: The news of the grant is likely to increase awareness of bacteriophages as a potential treatment for bacterial infections. This could lead to increased demand for bacteriophage-based therapies from patients, doctors, and other healthcare professionals.

Other notable news and developments

  • August 2023: The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) for phage therapy to treat a patient with a multidrug-resistant bacterial infection. This is the first time that phage therapy has been authorized for use in the United States.
  • July 2023: The European Medicines Agency (EMA) launched a new initiative to accelerate the development and approval of phage therapies. The initiative, called PhageBank, will provide researchers with access to a large collection of phages and support their efforts to develop new phage therapies.
  • June 2023: A multinational consortium of researchers published a study in the journal Nature Medicine that showed that phage therapy was effective in treating patients with chronic lung infections caused by Pseudomonas aeruginosa. The study is the largest and most rigorous clinical trial of phage therapy to date.
  • May 2023: The US Department of Defense awarded a $100 million contract to Intralytix, a company that develops phage therapies, to develop and manufacture phage therapies for military use.
  • April 2023: The World Health Organization (WHO) published a report that highlighted the potential of phage therapy to address the growing threat of antimicrobial resistance. The report called for more investment in research and development of phage therapies, as well as for regulatory reforms to make it easier to bring phage therapies to market.

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Bacteriophage Market

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Bacteriophage Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Major Industry Challenges
3.2.3. Key Growth Pockets
3.3. Attractive Investment Proposition,2021
3.3.1. Administration
3.3.2. Product
3.3.3. Application
3.3.4. Distribution Channel
3.4. Porter’s Five Forces Analysis
3.4.1. Threat of New Entrants
3.4.2. Bargaining Power of Buyers/Consumers
3.4.3. Bargaining Power of Suppliers
3.4.4. Threat of Substitute Types
3.4.5. Intensity of Competitive Rivalry
3.5. Value Chain Analysis

4. Market Positioning of Key Players, 2021
4.1. Company market share of key players, 2021
4.2. Top 6 Players
4.3. Top 3 Players
4.4. Major Strategies Adopted by Key Players

5. COVID 19 Impact Analysis
5.1. Global Bacteriophage Market Pre Vs Post COVID 19, 2019 – 2028
5.2. Impact on Import & Export
5.3. Impact on Demand & Supply

6. North America
6.1. North America Bacteriophage Market, by Country, 2016-2028(US$ Bn)
6.1.1. U.S.
6.1.2. Canada
6.1.3. Mexico
6.2. North America Bacteriophage Market, by Type, 2016-2028(US$ Bn)
6.2.1. Overview
6.2.2. Phage Probiotics
6.2.3. Phage Therapeutics
6.3. North America Bacteriophage Market, by Administration, 2016-2028(US$ Bn)
6.3.1. Overview
6.3.2. Oral
6.3.3. Topical
6.3.4. Solvents
6.3.5. Others
6.4. North America Bacteriophage Market, by Application, 2016-2028(US$ Bn)
6.4.1. Overview
6.4.2. Gastroenterology
6.4.3. Respiratory Infection Treatment
6.4.4. Skin Infection Treatment
6.4.5. Wound Prophylaxis
6.4.6. Urogenital Infection Treatment
6.4.7. Others
6.5. North America Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)
6.5.1. Overview
6.5.2. Retail Pharmacies
6.5.3. Hospital Pharmacies
6.5.4. Online Pharmacies
6.5.5. Other

7. Europe
7.1. Europe Bacteriophage Market, by Country, 2016-2028(US$ Bn)
7.1.1. UK
7.1.2. France
7.1.3. Germany
7.1.4. Italy
7.1.5. Russia
7.1.6. Ukraine
7.1.7. Spain
7.1.8. Belgium
7.1.9. Netherland
7.1.10. Austria
7.1.11. Sweden
7.1.12. Poland
7.1.13. Denmark
7.1.14. Switzerland
7.1.15. Rest of Europe
7.2. Europe Bacteriophage Market, by Type, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Phage Probiotics
7.2.3. Phage Therapeutics
7.2.4. Other
7.3. Europe Bacteriophage Market, by Administration, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Oral
7.3.3. Topical
7.3.4. Solvents
7.3.5. Others
7.4. Europe Bacteriophage Market, by Application, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Gastroenterology
7.4.3. Respiratory Infection Treatment
7.4.4. Skin Infection Treatment
7.4.5. Wound Prophylaxis
7.4.6. Urogenital Infection Treatment
7.4.7. Others
7.5. Europe Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)
7.5.1. Overview
7.5.2. Retail Pharmacies
7.5.3. Hospital Pharmacies
7.5.4. Online Pharmacies
7.5.5. Other

8. Asia Pacific
8.1. Asia Pacific Bacteriophage Market, by Country, 2016-2028(US$ Bn)
8.1.1. China
8.1.2. Japan
8.1.3. South Korea
8.1.4. India
8.1.5. Australia
8.1.6. New Zealand
8.1.7. Taiwan
8.1.8. Indonesia
8.1.9. Malaysia
8.1.10. Philippine
8.1.11. Rest of Asia Pacific
8.2. Asia Pacific Bacteriophage Market, by Type, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. Phage Probiotics
8.2.3. Phage Therapeutics
8.2.4. Other
8.3. Asia Pacific Bacteriophage Market, by Administration, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. Oral
8.3.3. Topical
8.3.4. Solvents
8.3.5. Others
8.4. Asia Pacific Bacteriophage Market, by Application, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. Gastroenterology
8.4.3. Respiratory Infection Treatment
8.4.4. Skin Infection Treatment
8.4.5. Wound Prophylaxis
8.4.6. Urogenital Infection Treatment
8.4.7. Others
8.5. Asia Pacific Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)
8.5.1. Overview
8.5.2. Retail Pharmacies
8.5.3. Hospital Pharmacies
8.5.4. Online Pharmacies
8.5.5. Other

9. Latin America
9.1. Latin America Bacteriophage Market, by Country, 2016-2028(US$ Bn)
9.1.1. Brazil
9.1.2. Argentina
9.1.3. Peru
9.1.4. Chile
9.1.5. Colombia
9.1.6. Rest of Latin America
9.2. Latin America Bacteriophage Market, by Type, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. Phage Probiotics
9.2.3. Phage Therapeutics
9.2.4. Other
9.3. Latin America Bacteriophage Market, by Administration, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. Oral
9.3.3. Topical
9.3.4. Solvents
9.3.5. Others
9.4. Latin America Bacteriophage Market, by Application, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. Gastroenterology
9.4.3. Respiratory Infection Treatment
9.4.4. Skin Infection Treatment
9.4.5. Wound Prophylaxis
9.4.6. Urogenital Infection Treatment
9.4.7. Others
9.5. Latin America Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)
9.5.1. Overview
9.5.2. Retail Pharmacies
9.5.3. Hospital Pharmacies
9.5.4. Online Pharmacies
9.5.5. Other

10. Middle East
10.1. Middle East Bacteriophage Market, by Country, 2016-2028(US$ Bn)
10.1.1. UAE
10.1.2. KSA
10.1.3. Israel
10.1.4. Turkey
10.1.5. Iran
10.1.6. Rest of Middle East
10.2. Middle East Bacteriophage Market, by Type, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. Phage Probiotics
10.2.3. Phage Therapeutics
10.2.4. Other
10.3. Middle East Bacteriophage Market, by Administration, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. Oral
10.3.3. Topical
10.3.4. Solvents
10.3.5. Others
10.4. Middle East Bacteriophage Market, by Application, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. Gastroenterology
10.4.3. Respiratory Infection Treatment
10.4.4. Skin Infection Treatment
10.4.5. Wound Prophylaxis
10.4.6. Urogenital Infection Treatment
10.4.7. Others
10.5. Middle East Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)
10.5.1. Overview
10.5.2. Retail Pharmacies
10.5.3. Hospital Pharmacies
10.5.4. Online Pharmacies
10.5.5. Other

11. Africa
11.1. Africa Bacteriophage Market, by Country, 2016-2028(US$ Bn)
11.1.1. South Africa
11.1.2. Egypt
11.1.3. Nigeria
11.1.4. Rest of Africa
11.2. Africa Bacteriophage Market, by Type, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. Phage Probiotics
11.2.3. Phage Therapeutics
11.2.4. Other
11.3. Africa Bacteriophage Market, by Administration, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. Oral
11.3.3. Topical
11.3.4. Solvents
11.3.5. Others
11.4. Africa Bacteriophage Market, by Application, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. Gastroenterology
11.4.3. Respiratory Infection Treatment
11.4.4. Skin Infection Treatment
11.4.5. Wound Prophylaxis
11.4.6. Urogenital Infection Treatment
11.4.7. Others
11.5. Africa Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)
11.5.1. Overview
11.5.2. Retail Pharmacies
11.5.3. Hospital Pharmacies
11.5.4. Online Pharmacies
11.5.5. Other
12. Global
12.1. Global Bacteriophage Market, by Type, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. Phage Probiotics
12.1.3. Phage Therapeutics
12.1.4. Other
12.2. Global Bacteriophage Market, by Administration, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. Oral
12.2.3. Topical
12.2.4. Solvents
12.2.5. Others
12.3. Global Bacteriophage Market, by Application, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. Gastroenterology
12.3.3. Respiratory Infection Treatment
12.3.4. Skin Infection Treatment
12.3.5. Wound Prophylaxis
12.3.6. Urogenital Infection Treatment
12.3.7. Others
12.4. Global Bacteriophage Market, by Distribution Channel, 2016-2028(US$ Bn)
12.4.1. Overview
12.4.2. Retail Pharmacies
12.4.3. Hospital Pharmacies
12.4.4. Online Pharmacies
12.4.5. Other

13. Company Profiles
13.1. Armata Pharmaceuticals, Inc.
13.2. Phagelux, Inc.
13.3. Nextbiotics
13.4. InnoPhage, Ltd
13.5. Locus Biosciences, Inc.
13.6. TechnoPhage
13.7. Eligo Bioscience SA
13.8. Phagomed Biopharma GmbH.
13.9. PhagePro, Inc.
13.10. Intralytix, Inc.
13.11. Adaptive Phage Therapeutics
13.12. Enbiotix, Inc.
13.13. Intodeworld, Inc.
13.14. BiomX Ltd.
13.15. Fixed-phage Ltd.
13.16. Micreos BV
13.17. ContraFect Corporation
13.18. Phi Therapeutics
13.19. OPTIPHARM Co., Ltd
13.20. Others

List of Figures

FIG. 1 Global Bacteriophage Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Bacteriophage Market Segmentation
FIG. 4 Global Bacteriophage Market, by Type, 2019 (US$ Bn)
FIG. 5 Global Bacteriophage Market, by Administration, 2019 (US$ Bn)
FIG. 6 Global Bacteriophage Market, by Distribution Channel, 2019 (US$ Bn)
FIG. 7 Global Bacteriophage Market, by Application, 2021 (US$ Bn)
FIG. 8 Global Bacteriophage Market, by Geography, 2021 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Geography, 2021
FIG. 10 Global Market Positioning of Key Bacteriophage Market Manufacturers, 2019
FIG. 11 Global Bacteriophage Market Value Contribution, By Type, 2021 & 2028 (Value %)
FIG. 12 Global Bacteriophage Market, by Phage Probiotics, Value, 2016-2028 (US$ Bn)
FIG. 13 Global Bacteriophage Market, by Phage Therapeutics, Value, 2016-2028 (US$ Bn)
FIG. 14 Global Bacteriophage Market Value Contribution, By Application, 2021 & 2028 (Value %)
FIG. 15 Global Bacteriophage Market, by Gastroenterology, Value, 2016-2028 (US$ Bn)
FIG. 16 Global Bacteriophage Market, by Respiratory Infection Treatment, Value, 2016-2028 (US$ Bn)
FIG. 17 Global Bacteriophage Market, by Skin Infection Treatment, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Bacteriophage Market, by Wound Prophylaxis, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Bacteriophage Market Value Contribution, By Administration, 2021 & 2028 (Value %)
FIG. 20 Global Bacteriophage Market, by Oral, 2016-2028 (US$ Bn)
FIG. 21 Global Bacteriophage Market, by Topical, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Bacteriophage Market, by Solvents, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Bacteriophage Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 24 Global Bacteriophage Market Value Contribution, By Distribution Channel, 2021 & 2028 (Value %)
FIG. 25 Global Bacteriophage Market, by Retail Pharmacies, 2016-2028 (US$ Bn)
FIG. 26 Global Bacteriophage Market, by Hospital Pharmacies, 2016-2028 (US$ Bn)
FIG. 27 Global Bacteriophage Market, by Online Pharmacies, 2016-2028 (US$ Bn)
FIG. 28 U.S. Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 29 Rest of North America Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 30 U.K. Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 31 Germany Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 32 France Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 33 Italy Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 34 Spain Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 35 Russia Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 36 BENELUX Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 37 Poland Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 38 Austria Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 39 Rest of Europe Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 40 Japan Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 41 China Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 42 India Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 43 South Korea Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 44 Australia Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 45 Southeast Asia Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 46 Rest of Asia Pacific Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 47 Middle East & Africa Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 48 South Africa Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 49 Nigeria Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 50 Egypt Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 51 GCC Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 52 Israel Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 53 Latin America Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 54 Mechanicalzil Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 55 Argentina Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 56 Colombia Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 57 Peru Bacteriophage Market, 2016-2028 (US$ Bn)
FIG. 58 Chile Bacteriophage Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Bacteriophage Market
TABLE 2 Global Bacteriophage Market, by Type, 2016-2028 (US$ Bn)
TABLE 3 Global Bacteriophage Market, by Application, 2016-2028 (US$ Bn)
TABLE 4 Global Bacteriophage Market, by Administration, 2016-2028 (US$ Bn)
TABLE 5 Global Bacteriophage Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 6 Global Bacteriophage Market, by Geography, 2016-2028 (US$ Bn)
TABLE 7 North America Bacteriophage Market, by Type, 2016-2028 (US$ Bn)
TABLE 8 North America Bacteriophage Market, by Application, 2016-2028 (US$ Bn)
TABLE 9 North America Bacteriophage Market, by Administration, 2016-2028 (
TABLE 10 North America Bacteriophage Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 11 North America Bacteriophage Market, by Country, 2016-2028 (US$ Bn)
TABLE 12 Europe Bacteriophage Market, by Type, 2016-2028 (US$ Bn)
TABLE 13 Europe Bacteriophage Market, by Application, 2016-2028 (US$ Bn)
TABLE 14 Europe Bacteriophage Market, by Administration, 2016-2028 (US$ Bn)
TABLE 15 Europe Bacteriophage Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 16 Europe Bacteriophage Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 17 Asia Pacific Bacteriophage Market, by Type, 2016-2028 (US$ Bn)
TABLE 18 Asia Pacific Bacteriophage Market, by Application, 2016-2028 (US$ Bn)
TABLE 19 Asia Pacific Bacteriophage Market, by Administration, 2016-2028 (US$ Bn)
TABLE 20 Asia Pacific Bacteriophage Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 21 Asia Pacific Bacteriophage Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 22 Latin America Bacteriophage Market, by Type, 2016-2028 (US$ Bn)
TABLE 23 Latin America Bacteriophage Market, by Application, 2016-2028 (US$ Bn)
TABLE 24 Latin America Bacteriophage Market, by Administration, 2016-2028 (US$ Bn)
TABLE 25 Latin America Bacteriophage Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 26 Latin America Bacteriophage Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 27 Middle East Bacteriophage Market, by Type, 2016-2028 (US$ Bn)
TABLE 28 Middle East Bacteriophage Market, by Application, 2016-2028 (US$ Bn)
TABLE 29 Middle East Bacteriophage Market, by Administration, 2016-2028 (US$ Bn)
TABLE 30 Middle East Bacteriophage Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 31 Middle East Bacteriophage Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 32 Africa Bacteriophage Market, by Type, 2016-2028 (US$ Bn)
TABLE 33 Africa Bacteriophage Market, by Application, 2016-2028 (US$ Bn)
TABLE 34 Africa Bacteriophage Market, by Administration, 2016-2028 (US$ Bn)
TABLE 35 Africa Bacteriophage Market, by Distribution Channel, 2016-2028 (US$ Bn)
TABLE 36 Africa Bacteriophage Market, by Country/Region, 2016-2028 (US$ Bn)

Frequently Asked Questions:

How COVID-19 Impacted the global Bacteriophage Market?

The COVID-19 pandemic created major hurdles to enterprises in the global bacteriophage therapy sector. With the inconsistencies in the transportation facility, obtaining raw materials for the production of medicine formulations was a major challenge. The COVID-19 epidemic hampered clinical trials in the United States, hurting key companies throughout the industry.

Which is the leading market for Bacteriophage Market?

North America dominates the bacteriophages therapy market and will maintain its dominance throughout the projection period. This is because bacteriophage provides quick recovery and therapeutic impact, and rising healthcare expenditure would further boost the market’s development rate in this region.

What are the key drivers for the growth of the Bacteriophage Market?

The rise in the incidence of various antibiotic-resistant illnesses around the world is expected to help the worldwide bacteriophage market grow.

Which is the major segment in Bacteriophage Market by Product?

In terms of product, the phage probiotics sector held around 95.5 percent of the market in 2021.

Which is the major segment in Bacteriophage Market by Application?

Gastroenterology is creating a big opportunity for Bacteriophage Probiotic Manufacturers. Gut health is becoming a major public health concern, and phage supplements fill an unmet demand by protecting the gut from harmful bacteria.

Nontuberculous Mycobacterial (NTM) Infection Market

Published:
Report ID: 33051

Plant Stem Cell Market

Published:
Report ID: 9766

Pharmaceutical Rapid Microbiology Testing Market

Published:
Report ID: 9476

Plant Stem Cell Nutrition Products Market

Published:
Report ID: 9775

Biological Data Visualization Market

Published:
Report ID: 32405

Bioprocess Validation Market

Published:
Report ID: 31245

Baculovirus Expression System Market

Published:
Report ID: 31033

Red Biotechnology Market

Published:
Report ID: 30876

Enzymatic DNA Synthesis Market

Published:
Report ID: 23339

Oligonucleotide API Market

Published:
Report ID: 23006

Next Generation Sequencing Market

Published:
Report ID: 14469

Small Molecule Drug Discovery Market

Published:
Report ID: 22652

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN